Can Ketamine Be Used To Treat Gambling Addiction? Awakn Life Sciences Wants To Find Out
Awakn Life Sciences Corp.
Psyched: Atai Launches ‘Salvia Divinorum’ Subsidiary, Mindset, Psilera and Wesana’s Preclinical Trials, Origin Raises $5M
Atai Life Sciences Launches New Salvia Divinorum Subsidiary
Atai Life Sciences (NASDAQ: ATAI) announced the launch of a new subsidiary that will research Salvinorin A, the active compound in salvia divinorum, a hallucinogenic herb native to Central America.
UK Psychedelics Co. Awakn Life Sciences Begins Listing On OTC Markets
Awakn Life Sciences Corp. (NEO: AWKN) (OTC Pink: AWKNF), a biotech company with clinical operations in the psychedelics space looking at the UK mental health markets, began trading on Monday in the U.S. OTC markets under the symbol “AWKNF.”